About
Technology
Issues
FAQ
Links
Official Page
Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.